Biofrontera Inc.
BFRI
$1.08
-$0.02-1.82%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 144.71% | -22.61% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 144.71% | -22.61% | |||
| Cost of Revenue | 47.14% | -22.60% | |||
| Gross Profit | 185.07% | -22.62% | |||
| SG&A Expenses | -15.65% | -2.17% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.47% | -5.97% | |||
| Operating Income | 172.62% | -23.61% | |||
| Income Before Tax | 184.90% | -25.27% | |||
| Income Tax Expenses | -100.00% | -71.43% | |||
| Earnings from Continuing Operations | 184.82% | -24.89% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 184.82% | -24.89% | |||
| EBIT | 172.62% | -23.61% | |||
| EBITDA | 173.85% | -23.83% | |||
| EPS Basic | 178.36% | -8.38% | |||
| Normalized Basic EPS | 168.70% | -8.66% | |||
| EPS Diluted | 178.36% | -8.38% | |||
| Normalized Diluted EPS | 168.70% | -8.66% | |||
| Average Basic Shares Outstanding | 8.24% | 15.24% | |||
| Average Diluted Shares Outstanding | 8.24% | 15.24% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||